[Fund Index | Funds By Family | Fund Top Performers]

Mutual Fund Top Performers - Specialty-Technology

As of 30-Jun-08

Select a symbol for a detailed quote and links to additional information.

Top Performers - 3 Month (out of 268) Fund Name Symbol Return Fidelity Select Network & Infrastruct FNINX 10.47% Berkshire Focus BFOCX 8.73% Franklin Technology A FTCAX 8.10% Franklin Technology Adv FRTCX 8.07% Franklin Technology R FTERX 7.98% Franklin Technology C FFTCX 7.95% Franklin Technology B N/A 7.92% Seligman Communications&Information I SCMIX 7.01% Seligman Communications&Information A SLMCX 6.85% Seligman Communications&Information R SCIRX 6.82%
Top Performers - 1 Year (out of 268) Fund Name Symbol Return Ivy Science & Technology I ISTIX 3.26% Ivy Science & Technology Y WSTYX 2.99% Ivy Science & Technology A WSTAX 2.90% Ivy Science & Technology R WSTRX 2.69% Waddell & Reed Adv Science & Tech Y USTFX 2.22% Ivy Science & Technology C WSTCX 2.06% Berkshire Focus BFOCX 2.02% Ivy Science & Technology B WSTBX 1.86% Waddell & Reed Adv Science & Tech A UNSCX 1.84% Ivy Science & Technology E ISTEX 1.71%		Top Performers - 3 Year (out of 257) Fund Name Symbol Ann. Ret. MFS Technology I MTCIX 14.15% MFS Technology R4 MTCJX 14.06% MFS Technology A MTCAX 13.74% MFS Technology R3 MTCHX 13.71% Seligman Communications&Information I SCMIX 13.49% MFS Technology R2 MTERX 13.46% MFS Technology B MTCBX 13.06% MFS Technology C MTCCX 13.04% Seligman Communications&Information A SLMCX 12.96% MFS Technology R1 MTCKX 12.94%
Top Performers - 5 Year (out of 229) Fund Name Symbol Ann. Ret. Matthews Asian Technology MATFX 17.25% Columbia Technology Z CMTFX 17.23% Columbia Technology A CTCAX 16.92% Columbia Technology B CTCBX 16.08% Waddell & Reed Adv Science & Tech Y USTFX 15.87% Ivy Science & Technology Y WSTYX 15.56% Waddell & Reed Adv Science & Tech A UNSCX 15.48% Ivy Science & Technology A WSTAX 15.36% Ivy Science & Technology C WSTCX 14.39% Waddell & Reed Adv Science & Tech C WCSTX 14.15%

Get Morningstar's portfolio tools, data, and editorial insights, plus Analyst Reports on 1,450 stocks and 2,000 funds. Start your free 14-day trial today.